Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan.

Ei, Shigenori; Takahashi, Shinichiro; Ogasawara, Toshihito; Mashiko, Taro; Masuoka, Yoshihito; Nakagohri, Toshio

Ei, Shigenori; Takahashi, Shinichiro; Ogasawara, Toshihito; Mashiko, Taro; Masuoka, Yoshihito; Nakagohri, Toshio.

Afiliação

Ei S; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Takahashi S; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Ogasawara T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Mashiko T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Masuoka Y; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.
Nakagohri T; Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Japan.

Gut Liver ; 17(5): 698-710, 2023 09 15.

Article em En | MEDLINE | ID: mdl-36843421

Assuntos

Carcinoma Ductal Pancreático; Neoplasias Pancreáticas; Humanos; Terapia Neoadjuvante; Japão; Neoplasias Pancreáticas/tratamento farmacológico; Neoplasias Pancreáticas/cirurgia; Carcinoma Ductal Pancreático/cirurgia; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Pancreatectomia; Neoplasias Pancreáticas

Palavras-chave

Adjuvant chemotherapy; Chemoradiotherapy; Clinical trial; Neoadjuvant therapy; Pancreatic neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Gut Liver Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google